Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6132286 | Current Opinion in Microbiology | 2009 | 7 Pages |
Abstract
Bacteria of Shigella spp., the causative agents of shigellosis in humans, possess a repertoire of â¼25-30 effectors injected into host cells by a type III secretion apparatus (T3SA). The T3SA activity is activated upon contact of bacteria with cells and controls expression of some effectors. Recent structural and functional studies suggest that two different sets of effectors are involved in inducing actin cytoskeleton reorganization to promote entry of bacteria into epithelial cells and in modulating cell signaling pathways to dampen innate immune responses induced upon infection, respectively. Schematically, effectors involved in entry are produced independently of the T3SA activity, whereas effectors involved in controlling the cell responses are produced upon activation of the T3SA.
Related Topics
Life Sciences
Immunology and Microbiology
Microbiology
Authors
Claude Parsot,